Challenge More than 770,000 Canadians are currently living with ASD, FASD or CP — the most common neurodevelopmental disabilities. Treatments for these conditions have been focused on behavioural and symptom management because there now are no cures or effective preventions. For health care decision-makers to be able to make informed choices, there needs to be [...]
Health Economic Assessment of KBHN Interventions
Nicolas Turgeon-Morin2023-05-04T07:38:18-08:00Challenge Disability is associated with increased health and social service costs that vary significantly with the severity of the disability. In Canada, estimating the costs associated with a neurodevelopmental disorder (NDD) is challenging because the diagnosis process is lengthy. There are many costs to consider throughout a person’s lifespan, such as medical care, educational expenses [...]
